NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 48 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,564 | -50.5% | 19,264 | -49.2% | 0.00% | – |
| Q4 2022 | $7,207 | -78.8% | 37,891 | +106.6% | 0.00% | – |
| Q1 2022 | $34,000 | -88.2% | 18,339 | -82.2% | 0.00% | – |
| Q4 2021 | $288,000 | -22.8% | 102,864 | -0.4% | 0.00% | – |
| Q3 2021 | $373,000 | -35.1% | 103,248 | -14.1% | 0.00% | – |
| Q2 2021 | $575,000 | +16.6% | 120,242 | +80.2% | 0.00% | – |
| Q1 2021 | $493,000 | -11.3% | 66,719 | -16.1% | 0.00% | – |
| Q4 2020 | $556,000 | – | 79,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |